SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Rapid antidepressant effects associated with ketamine have shifted the landscape for the

GABAA and NMDA receptor density alterations and their behavioral

N-Methyl D-aspartate receptor subunit signaling in fear extinction

PDF) Cannabinoids and Vanilloids in Schizophrenia

PDF) Neuroprogression in schizophrenia: Pathways underpinning

NMDA receptor trafficking in synaptic plasticity and

PDF) The use of Amantadine in Cognitive and Behavioral Recovery

NMDA receptor-targeted enrichment of CaMKIIα improves fear memory

PDF) Pharmacological treatment of generalized anxiety disorder

PDF) Neuroprogression in schizophrenia: Pathways underpinning

Cell-type specific modulation of NMDA receptors triggers

Recent Findings in NMDA Receptor Research and Its Impact on the

PDF) Neuroprogression in schizophrenia: Pathways underpinning

PDF) Cannabinoids and Vanilloids in Schizophrenia

Frontiers Targeting mGlu Receptors for Optimization of